| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f7031a0a7df6f5148e9d259240dd21 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_346414e4795e15d8d23198cdf739bbcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c661a57b7e3e77c3a1ba0136ab249a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7c2b86fd4ffad328d7b2720d6bfeb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd820e91ae1e6c9d0ac16b38b92d5076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30cb09065a4c580e365da96aee1a0b9 |
| publicationDate |
2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111303095-A |
| titleOfInvention |
A kind of hydrogen sulfide donor based on α-methylene-γ-lactone ring structure and preparation method and application thereof |
| abstract |
The present invention relates to a hydrogen sulfide donor compound based on α-methylene-γ-lactone ring structure, a preparation method and application thereof, which are formed by α-methylene-γ-lactone ring structure and sulfur With a dimer structure, the series of compounds can continuously release hydrogen sulfide and can be used as a hydrogen sulfide donor. Some compounds of the present invention have obvious tumor-inhibiting activity, which lays a foundation for the development of anti-tumor drugs. |
| priorityDate |
2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |